Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 7.12% |
| 4 | Industrials | 5.11% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
PUT
Elevance Health
ELV
$87.3B
| $78.9M | 0.05% |
163,500
+18,200
| +13% | +$9M |
|
|
DOCU
402
DocuSign
DOCU
$11.9B
| $78.8M | 0.05% |
1,374,135
+157,762
| +13% | +$12.8M |
|
403
Macy's
M
$6.1B
| $78.7M | 0.05% |
4,298,416
+1,550,597
| +56% | +$35.1M |
|
404
MongoDB
MDB
$32.4B
| $78.6M | 0.05% |
302,838
+234,956
| +346% | +$73.5M |
|
405
PUT
Marriott International
MAR
$93.9B
| $78.4M | 0.05% |
576,700
+143,500
| +33% | +$23.7M |
|
406
Ferguson
FERG
$45.7B
| $78.2M | 0.05% |
706,265
+535,221
| +313% | +$64.8M |
|
|
LSI
407
DELISTED
Life Storage, Inc.
LSI
| $78.1M | 0.05% |
699,720
+15,922
| +2% | +$1.97M |
|
|
MRO
408
DELISTED
Marathon Oil Corporation
MRO
| $78.1M | 0.05% |
3,475,320
-2,049,082
| -37% | -$54.8M |
|
|
JNPR
409
DELISTED
Juniper Networks
JNPR
| $78M | 0.05% |
2,736,231
+2,262,674
| +478% | +$71.4M |
|
410
CALL
Pfizer
PFE
$159B
| $77.8M | 0.05% |
1,483,200
+849,200
| +134% | +$43.3M |
|
411
Halliburton
HAL
$28.9B
| $77.7M | 0.05% |
2,476,139
-790,282
| -24% | -$29.5M |
|
412
CALL
Visa
V
$714B
| $77.5M | 0.05% |
393,700
-60,500
| -13% | -$12.5M |
|
413
CALL
Goldman Sachs
GS
$302B
| $77.5M | 0.05% |
260,900
-105,900
| -29% | -$33M |
|
414
CALL
Comcast
CMCSA
$95.9B
| $77.5M | 0.05% |
1,974,100
-441,400
| -18% | -$18.9M |
|
415
Icon
ICLR
$13.4B
| $77M | 0.05% |
355,264
+82,448
| +30% | +$18.5M |
|
416
AstraZeneca
AZN
$259B
| $76.6M | 0.05% |
579,886
+403,983
| +230% | +$53M |
|
417
PUT
Tyson Foods
TSN
$20.4B
| $76.6M | 0.05% |
890,000
+412,300
| +86% | +$36.9M |
|
418
ATI
ATI
$28.6B
| $76.4M | 0.05% |
3,362,508
+1,627,647
| +94% | +$42.9M |
|
419
PUT
Nike
NKE
$60.5B
| $76M | 0.05% |
743,200
-357,800
| -32% | -$42.3M |
|
420
CALL
PepsiCo
PEP
$197B
| $75.9M | 0.05% |
455,300
+159,000
| +54% | +$26.8M |
|
421
Teva Pharmaceuticals
TEVA
$43B
| $75.8M | 0.05% |
10,086,305
-1,346,502
| -12% | -$11.7M |
|
422
Teck Resources
TECK
$34.4B
| $75.5M | 0.05% |
2,470,888
+125,036
| +5% | +$4.93M |
|
|
EXE
423
Expand Energy Corp
EXE
$22.3B
| $75.5M | 0.05% |
931,350
+654,998
| +237% | +$59.2M |
|
424
Range Resources
RRC
$9.64B
| $75.2M | 0.05% |
3,036,947
+1,387,280
| +84% | +$42.5M |
|
425
Brown-Forman Class B
BF.B
$13.2B
| $74.7M | 0.05% |
1,064,100
+871,130
| +451% | +$58.4M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.